Physician profile
Gail A Besson
NPI 1639287055
$420.94
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $106 · 2022: $21.78 · 2023: $138 · 2024: $155.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $254 · Education: $39.39.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $253.85 |
| Education | $39.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Roche Diagnostics Corporation | $105.92 | 2019 | |
| Sumitomo Pharma America, INC. | $61.99 | 2023 | Myfembree |
| Organon LLC | $51.97 | 2023 | Nexplanon |
| Merck Sharp & Dohme LLC | $43.99 | 2024 | Gardasil 9, Gardasil, Capvaxive |
| Pfizer INC. | $29.81 | 2024 | |
| Shield Therapeutics INC | $24.78 | 2024 | |
| Renalytix Ai, INC. | $24.54 | 2024 | Kidneyintelx Blood Collection Convenience Kit |
| Exact Sciences Corporation | $23.81 | 2023 | Cologuard Collection Kit |
| Myovant Sciences INC. | $21.78 | 2022 | |
| Viiv Healthcare Company | $17.22 | 2024 | Dovato |
| Lilly USA, LLC | $15.13 | 2024 | Zepbound, Mounjaro |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gail Besson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.